| Ident. | Authors (with country if any) | Title |
|---|
| 000F91 (2012) |
Robert Chinnapongse [États-Unis] ; Kristen Gullo [États-Unis] ; Paul Nemeth [États-Unis] ; YUXIN ZHANG [États-Unis] ; Lynn Griggs [États-Unis] | Safety and Efficacy of Botulinum Toxin Type B for Treatment of Sialorrhea in Parkinson's Disease: A Prospective Double-Blind Trial |
| 001030 (2012) |
Andrew Lees (neurologue) [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Karla M. Eggert [Allemagne] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; Federico Micheli [Argentine] ; M. Maral Mouradian [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Eduardo Tolosa [Espagne] ; David Squillacote [États-Unis] ; Dinesh Kumar [États-Unis] | Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease |
| 001143 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gunther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis] | Donepezil in Parkinson's Disease Dementia: A Randomized, Double-Blind Efficacy and Safety Study |
| 001565 (2011) |
Rebecca Stowe [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Kelly Handley [Royaume-Uni] ; Alexandra Furmston [Royaume-Uni] ; Katherine Deane [Royaume-Uni] ; J. J. Van Hilten [Pays-Bas] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease |
| 001581 (2011) |
Codrin Lungu [États-Unis] ; Barbara I. Karp [États-Unis] ; Katharine Alter [États-Unis] ; Regina Zolbrod [États-Unis] ; Mark Hallett [États-Unis] | Long‐term follow‐up of botulinum toxin therapy for focal hand dystonia: Outcome at 10 years or more |
| 001682 (2011) |
Joseph Jankovic [États-Unis] ; Cynthia Comella [États-Unis] ; Angelika Hanschmann [Allemagne] ; Susanne Grafe [Allemagne] | Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial |
| 001888 (2011) |
Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France |
| 001A21 (2010) |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
| 001D19 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 001F15 (2010) |
| Safety and Tolerability of High-Dosage Coenzyme Q10 in Huntington's Disease and Healthy Subjects |
| 002139 (2009) |
David Devos [France] | Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease |
| 002247 (2009) |
David Grabli [France] ; Claire Ewenczyk [France] ; Maria-Clara Coelho-Braga [France] ; Christelle Lagrange [France] ; Valerie Fraix [France] ; Philippe Cornu [France] ; Alim-Louis Benabid [France] ; Marie Vidailhet [France] ; Pierre Pollak [France] | Interruption of deep brain stimulation of the globus pallidus in primary generalized dystonia |
| 002519 (2009) |
M. Mar Trujillo-Martin [Espagne] ; Pedro Serrano-Aguilar [Espagne] ; Fernando Monton-Alvarez [Espagne] ; Romen Carrillo-Fumero [Espagne] | Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review |
| 002B91 (2007) |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study |
| 002F81 (2007) |
Richard M. Trosch [États-Unis] ; Charles H. Adler [États-Unis] ; Eric J. Pappert [États-Unis] | Botulinum toxin type B (Myobloc®) in subjects with hemifacial spasm: Results from an open‐label, dose‐escalation safety study |
| 003302 (2006) |
Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis] | Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease |
| 003454 (2006) |
Vincent Chung [Hong Kong] ; Liang Liu [Hong Kong] ; Zhaoxiang Bian [Hong Kong] ; Zhongzhen Zhao [Hong Kong] ; Wai Leuk Fong [Hong Kong] ; Wan Fung Kum [Hong Kong] ; Jing Gao [Hong Kong] ; Min Li [Hong Kong] | Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: A systematic review |
| 003858 (2005) |
Brian Berman [États-Unis] ; Lauren Seeberger [États-Unis] ; Rajeev Kumar [États-Unis] | Long‐term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia |
| 003859 (2005) |
J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jürgen Köster [Allemagne] ; Gianni Pezzoli [Italie] ; Leandro Provinciali [Italie] | Long‐term efficacy and safety of pramipexole in advanced Parkinson's disease: Results from a European multicenter trial |
| 003861 (2005) |
Nicte I. Mejia [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Joseph Jankovic [États-Unis] | Long‐term botulinum toxin efficacy, safety, and immunogenicity |
| 003935 (2005) |
Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Sharon Evans [États-Unis] ; Paul J. Feustel [États-Unis] | Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia |
